The forecasted import value of penicillins or streptomycins in dosage forms to Canada shows a steady decline from $30.926 million in 2024 to $30.142 million by 2028. This represents a slight year-on-year decrease of approximately 0.65% to 0.7%. The value stood at $31 million in 2023, suggesting a consistent downward trend.

Future trends to watch for:

Potential shifts in global pharmaceutical supply chains affecting import volumes.
Regulatory changes impacting medication imports to Canada.
Economic factors and healthcare demands influencing import requirements.